Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
GSK is paying $124 per share for Cambridge, Mass.-based Nuvalent, a 26% premium to the biotechs average share price over the last 30 days
These are trademarked medications that have received FDA approval for specific indications like type 2 diabetes or chronic weight management
This generally covers follow up visits and other clinic costs associated with providing the injections
Clinicians should maintain a high index of suspicion for alternative diagnoses and investigate appropriately when patients report persistent or severe upper gastrointestinal symptoms
US$ 27.26
US$ 25.79
US$ 22.29
US$ 27.52
US$ 26.31
US$ 24.84
